Waterloo Capital’s Madrigal Pharmaceuticals MDGL Stock Holding History

Waterloo Capital’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.33M	Buy	+9,926	New	+$5.08M	0.3%	78

Other funds holding MDGL

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

EAM

EULAV Asset Management Sarasota, Florida $3.13B AUM 23.04% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Waterloo Capital's MDGL Position: Q2 2026 in Review

Waterloo Capital opened a new position in Madrigal Pharmaceuticals (MDGL) in Q2 2026: 9,926 shares worth $5.33M. The stake represents 0.3% of the portfolio and ranks #78 among its holdings.

95 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Waterloo Capital held 9,926 shares of Madrigal Pharmaceuticals worth $5.33M as of Q2 2026.
Madrigal Pharmaceuticals was a new Waterloo Capital position in Q2 2026.
Madrigal Pharmaceuticals made up 0.3% of Waterloo Capital's portfolio in Q2 2026, its #78 holding.
95 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Waterloo Capital's 13F filing for Q2 2026, filed 29 Jul 2026.